Low AMH Causes: Age, Surgery and Test Timing

Klein, Thomas; Weber, Hans; Mitchell, Sarah

What a Low AMH Result Actually Means

A low AMH result usually means fewer small growing follicles are detectable at that point in time; it does not mean you have no eggs, cannot become pregnant naturally, or are about to enter menopause. In clinical practice, AMH is most useful for estimating response to ovarian stimulation, not for setting a countdown clock on spontaneous fertility.

Anti-Müllerian hormone is made by granulosa cells around pre-antral and small antral follicles, generally those measuring roughly 2 to 8 mm on ultrasound. A lower concentration therefore reflects the current population of these recruitable follicles, rather than the total number of eggs remaining. Kantesti is an AI blood test analyzer that places AMH alongside age, FSH, estradiol and the laboratory method rather than treating one flagged result as a prognosis.

The American Society for Reproductive Medicine states that ovarian reserve tests predict ovarian response to stimulation more reliably than they predict natural conception or live birth independent of age (ASRM Practice Committee, 2020). I have seen a 31-year-old with AMH of 0.6 ng/mL conceive without treatment, and a 39-year-old with AMH of 3.0 ng/mL still need help because of tubal or sperm factors. Those are not contradictions; AMH answers a narrower question.

Values are reported as ng/mL in many countries and pmol/L in others; 1.0 ng/mL is approximately 7.14 pmol/L. A laboratory reference interval is a statistical comparison group, not a fertility guarantee, which is why an out-of-range flag deserves context rather than panic. Our biomarker reference guide explains why laboratory flags and clinical decisions are not the same thing.

The practical distinction patients miss

AMH is a quantity marker, while age remains a stronger marker of egg chromosome risk. At age 42, an AMH of 2.0 ng/mL may indicate a reasonable stimulation response, yet age-related embryo aneuploidy remains the limiting issue; at age 27, an AMH of 0.7 ng/mL may warrant earlier planning but does not diagnose poor egg quality.

Age Is the Leading Cause of Low AMH

Age is the leading cause of low AMH, because the pool of follicles declines from before birth onward and the decline becomes less predictable in the late 30s. Two people of the same age can have AMH values several-fold apart, so no single age chart can tell an individual story.

Median AMH values broadly fall from the 20s through the 40s, but a healthy 30-year-old can naturally sit below 1.0 ng/mL and a healthy 40-year-old can sit above it. In my 15 years reviewing reproductive hormone panels, the error I most often see is comparing a 38-year-old to a generic adult interval instead of to age-specific expectations. The useful question is usually whether the result fits the person's age, ultrasound count and plans.

A rapid-looking fall can be real, but it can also reflect switching from one assay to another or ordinary biological variation. Within-person AMH variation of around 20% is plausible even when cycles are regular, and differences can be larger at low concentrations. Use the same laboratory when possible, much as you would when comparing changes between blood-test visits.

As of August 6, 2026, no diet, supplement, exercise plan, or detox has been shown to rebuild the age-related follicle pool in a clinically meaningful way. That can sound blunt, but it protects patients from expensive promises. What can change is the quality of the information used for planning: repeat testing under comparable conditions, antral follicle count, and timely specialist advice.

Why AMH Cutoffs Differ Between Laboratories

There is no universal AMH normal range, because assay calibration, reporting units, and the population used to create a reference interval differ. In fertility practice, an AMH below about 1.0 ng/mL often signals a lower expected response to stimulation, while a value below 0.5 ng/mL suggests a particularly low response in many protocols.

The familiar labels low, normal, and high oversimplify a continuous hormone measurement. A value of 0.8 ng/mL may be below an age-based median but still yield several eggs during IVF, whereas 2.5 ng/mL does not prove easy conception. The threshold exists mainly because clinicians need to anticipate medication dose, monitoring, and the risk of an overly weak or excessive response.

Older AMH assays were especially difficult to compare, and even current automated methods should not be treated as perfectly interchangeable. If a report says 5 pmol/L, that is roughly 0.70 ng/mL, not 5 ng/mL; unit confusion is surprisingly common when patients obtain care in more than one country. Kantesti AI reads units and laboratory ranges from uploaded reports before comparing results across time.

Thomas Klein, MD, advises patients not to repeat an AMH test merely to chase a better number within days. Repeat it when there is a clear reason: a different method, a result that conflicts with ultrasound, a recent medication change, or a treatment decision that depends on it. Our AI accuracy checklist can help identify transcription and unit errors before a consultation.

Common reference band About 1.0-4.0 ng/mL Often predicts an average stimulation response; age and assay remain essential context.

Higher result >4.0 ng/mL Can occur with polycystic ovarian morphology and may predict a stronger stimulation response.

Lower response band 0.5-1.0 ng/mL Often predicts fewer recruitable follicles during stimulation, not infertility.

Very low response band <0.5 ng/mL Usually merits individualized fertility discussion; it is not an emergency result.

AMH Test Timing: Cycle Day, Pregnancy and Recent Changes

AMH can usually be measured on any menstrual-cycle day, unlike FSH and estradiol, but it is not perfectly flat across the cycle. For a result near a treatment threshold, drawing AMH at a similar cycle phase and using the same laboratory makes the comparison more credible.

Most clinics accept a random AMH draw because cycle variation is smaller than the swings seen with estradiol or progesterone. Still, some patients have 15% to 30% variation across a cycle, especially near the lower end of the assay range. A result of 0.45 followed by 0.60 ng/mL may therefore represent normal fluctuation rather than a meaningful recovery.

Pregnancy often lowers measured AMH, and levels can remain altered in the postpartum period, so it is a poor time to assess long-term reserve. Acute illness is less clearly influential than it is for cortisol or thyroid testing, but I would avoid making major fertility decisions from a panel taken during hospital admission. Similar timing principles apply to other hormone tests, including estradiol testing on birth control.

Kantesti is an AI lab test interpretation service that records collection date, reported units and prior values so that an apparent AMH fall is not separated from its testing circumstances. A single result cannot show the slope of ovarian ageing. A well-documented series, interpreted carefully, can.

How Ovarian Surgery Can Lower AMH

Ovarian surgery can lower AMH when it removes follicles or affects nearby tissue, with endometrioma cystectomy carrying the clearest and most consistent signal. The decline is often greater after bilateral surgery, repeat operations, or more extensive removal of cyst wall tissue.

An endometrioma can itself be associated with lower AMH before any procedure, which makes the surgery-versus-disease question genuinely difficult. After cystectomy, AMH may drop sharply in the first weeks and then partly recover over 6 to 12 months, although recovery is not guaranteed. This is why a result drawn two weeks after an operation should not automatically be presented as the final reserve estimate.

The balance is individualized: leaving an endometrioma alone may complicate pain, infection risk during egg collection, or access to follicles, while operating can reduce reserve. Bilateral cystectomy is particularly relevant because both sides contribute to the hormone measurement. A prior ovarian torsion, benign cyst removal, or ovarian drilling should also appear in the history given to a reproductive endocrinologist.

Before elective surgery, ask whether an ultrasound-based antral follicle count and fertility preservation discussion would change the plan. The same principle applies when a blood test is being used for IVF decisions; see our guide to baseline IVF laboratory tests.

Medicines That Can Temporarily Change AMH

Combined hormonal contraception can modestly suppress measured AMH, commonly by about 20% to 30%, and the effect appears reversible in many users. This does not mean everyone should stop contraception before testing; stopping may create pregnancy risk or worsen symptoms, so the decision belongs with the prescriber.

Long-term pills, patches, rings, some progestin methods, and GnRH-based treatments can alter follicle activity or the measured hormone concentration. The evidence is not equally strong for every formulation, which is why I avoid claiming that a specific medicine explains every low value. A useful report includes the exact medicine, dose, start date, and whether cycles are suppressed.

High-dose biotin can interfere with certain immunoassays, although the direction and size of error depend on the assay design; it is not a proven common explanation for low AMH. Do not stop prescribed medicines in order to improve a laboratory number. Instead, ask the laboratory or clinician whether the manufacturer identifies relevant interference and whether a repeat on another method is sensible.

This is one reason Kantesti’s AI-powered blood test analysis tool asks users to review medication context before generating an interpretation. If irregular bleeding or medication-related hormonal questions are part of the picture, our guide to blood tests for irregular periods covers the complementary tests clinicians commonly consider.

Smoking, Body Weight and Illness: What Is Actually Reversible?

Smoking is associated with lower AMH in several observational studies, while the evidence for weight loss, supplements, and stress reduction raising AMH is weak or inconsistent. Modifiable habits still matter for pregnancy health and treatment outcomes, but they should not be marketed as ovarian-reserve restoration.

Smoking may accelerate follicle depletion through oxidative and toxic effects, although the exact size of the association differs by study population and exposure measurement. Stopping smoking is sensible at any AMH level because it improves broader reproductive and cardiovascular health. The result may not rebound dramatically, but preventing further exposure remains worthwhile.

Very low energy availability, eating disorders, intensive endurance training, and severe obesity can interrupt ovulation through hypothalamic and metabolic pathways. In these settings, AMH may be normal, low, or occasionally hard to interpret; absent periods are never explained by AMH alone. I have seen athletes assume that a low-normal AMH caused amenorrhea when energy deficiency was the more immediately treatable issue.

Vitamin D correction, sleep, protein intake, and a Mediterranean-style dietary pattern may support general health, but none has proven to reverse follicle depletion. For an evidence-based preconception review rather than supplement shopping, see our blood tests before pregnancy.

Genetic and Autoimmune Reasons for Low AMH

Genetic conditions and autoimmune ovarian insufficiency are uncommon but clinically important low AMH causes, especially before age 35 or when periods become infrequent. AMH alone cannot diagnose primary ovarian insufficiency, also called POI.

A family history of menopause before age 40, fragile X-related disorders, Turner syndrome or mosaicism, and certain chromosome changes can increase the likelihood of early follicle loss. Fragile X premutation testing is not a routine response to every low AMH result, but it is often considered in unexplained POI or a suggestive family history. The conversation is about genetics, relatives, and reproductive choices—not just a number.

Autoimmune disease can coexist with POI, particularly thyroid or adrenal autoimmunity, but broad immune panels in every person with low AMH create more false positives than answers. The concerning pattern is low AMH plus four or more months of absent or irregular periods, menopausal symptoms, and elevated FSH. A high FSH is explored in more detail in our guide to high FSH causes.

The 2024 international POI guideline uses an FSH concentration above 25 IU/L with menstrual disturbance as a central diagnostic clue; AMH is supportive, not the primary diagnostic test. Thomas Klein, MD, would usually confirm the clinical pattern before ordering niche genetic or adrenal studies. Testing should answer a decision, not merely widen the search.

When a Low AMH Test Should Be Repeated

Repeat a low AMH result when the result conflicts with clinical findings, was measured during pregnancy or shortly after surgery, or comes from a different assay than the prior test. Repeating it routinely every month rarely adds useful information and can create anxiety from normal variation.

A sensible confirmation pathway starts with the original report: check the unit, assay, date, pregnancy status, hormone use, recent surgery, and cancer treatment history. Then compare it with menstrual pattern, day 2 to 4 FSH and estradiol when indicated, and antral follicle count. A discordance such as AMH 0.3 ng/mL with 18 antral follicles deserves a closer look rather than an automatic label.

Allow time after a major hormonal transition or ovarian procedure before repeating, often several months rather than several days. There is no universal interval because the reason for testing matters; someone about to start chemotherapy needs a different timeline from someone considering IVF next year. The purpose should be written down before the tube is processed.

Keep an image of the full laboratory report, not only the highlighted value. Our lab result tracker lists the practical details that make a future comparison medically meaningful.

Which Tests Make a Low AMH Result More Useful?

Antral follicle count and age are the most useful companions to AMH when estimating ovarian stimulation response. FSH, estradiol, TSH, prolactin, pregnancy testing, and semen or tubal assessment may be more relevant than AMH for explaining why conception has not occurred.

A transvaginal ultrasound antral follicle count estimates follicles typically 2 to 10 mm in both ovaries and gives an independent reserve signal. AMH and follicle count often agree, but not always; ultrasound can be limited by endometriosis, prior surgery, body habitus, or an inexperienced scan. Agreement between two imperfect tests is reassuring, while disagreement tells the clinician where to look harder.

FSH above 25 IU/L with cycle disturbance raises concern for POI, while a normal FSH does not rule out lower reserve. Estradiol above roughly 60 to 80 pg/mL early in a cycle can suppress FSH and make it look deceptively reassuring. Thyroid and prolactin testing is not an AMH add-on by default, but both can contribute to cycle irregularity when symptoms or history point that way.

Kantesti AI organizes these results as a time-stamped hormone pattern rather than implying that every marker carries equal weight. For a broader clinical framework, our women’s hormonal health guide explains where AMH fits and where it does not.

Low AMH Does Not Equal Immediate Infertility

Low AMH does not reliably predict the chance of natural pregnancy in the next 6 to 12 months when age and regular ovulation are considered. It is far better at predicting how many follicles may respond to IVF medicines than whether sperm can reach an egg this cycle.

ASRM’s 2020 committee opinion cautions against using ovarian reserve tests as screening tests for fertility in people without infertility. The reason is biological: conception requires ovulation, open tubes, sperm function, timing, implantation, and embryo chromosome competence. AMH measures only one limited part of that pathway.

For someone under 35 with regular cycles, seeking assessment is generally reasonable after 12 months of unprotected intercourse; at age 35 or older, many guidelines use 6 months, and sooner is appropriate with absent cycles, known tubal disease, prior gonadotoxic treatment, or a partner factor. A low result can justify earlier discussion, but it should not be used to blame a patient for not conceiving.

Male-factor evaluation is often missed when AMH dominates the conversation. A basic semen analysis interpretation can be more actionable than repeating AMH, particularly when cycles are regular and ultrasound is reassuring.

What Low AMH Changes in IVF Planning

In IVF, low AMH primarily helps clinicians anticipate a lower oocyte yield and tailor stimulation rather than determine whether treatment is futile. A very low value may mean fewer retrieved eggs per cycle, but pregnancy and live birth remain possible, particularly at younger ages.

Clinics may use AMH to choose a starting gonadotropin dose, counsel about cancellation risk, and discuss whether more than one retrieval could be needed. Higher medication doses cannot force dormant follicles into the cycle, so the goal is an appropriate response rather than the biggest possible dose. This is an area where clinician preferences differ, and the evidence does not support one universal protocol for every low-AMH patient.

A low AMH value can also help identify people at low risk of ovarian hyperstimulation syndrome, whereas very high AMH raises the opposite concern. It does not determine embryo quality; age remains the dominant predictor of embryo chromosome status. For that reason, an AMH of 0.4 ng/mL at age 29 and the same value at age 43 lead to very different counseling.

Kantesti’s neural network can summarize AMH trends and related laboratory context, but medication selection and fertility treatment must remain a clinician-led decision. Our methods and physician oversight are described in the medical validation standards, and patients should bring the original report to a reproductive specialist.

A Calm, Practical Plan After a Low AMH Result

After a low AMH result, first verify the unit, assay, age context, medication use, and reason the test was ordered; then decide whether timing-sensitive fertility planning is needed. Low AMH is not an emergency laboratory result, but delay can matter when age, symptoms, or upcoming treatment affect options.

Book a clinician review promptly if you are under 40 with missed or increasingly irregular periods, hot flushes, night sweats, or FSH above 25 IU/L. Seek pre-treatment fertility advice before chemotherapy, pelvic radiation, or planned bilateral endometrioma surgery whenever possible. If you are simply curious about future fertility, a discussion can be helpful without turning a single test into a crisis.

Bring three things to that appointment: the full laboratory report, a concise menstrual and medication history, and a clear statement of your reproductive timeline. Ask whether antral follicle count, partner testing, tubal assessment, or fertility preservation information would alter your choices. In my experience, most patients leave less anxious when the conversation moves from a frightening flag to a concrete plan.

Kantesti is used by people in more than 127 countries to organize laboratory history, but our interpretation is educational and does not replace diagnosis or treatment. Our Medical Advisory Board oversees clinical review standards, and complex reproductive hormone results deserve care from a licensed clinician who knows your history.

Frequently Asked Questions

What is the most common cause of low AMH?

Age-related decline in the number of developing follicles is the most common cause of low AMH. AMH generally falls across the reproductive years, often with a less predictable decline after age 35, although people of the same age can differ by several-fold. A result below 1.0 ng/mL, or about 7.1 pmol/L, often predicts lower response to IVF stimulation but does not diagnose infertility. Ovarian surgery, chemotherapy, hormonal contraception, pregnancy, and laboratory-method differences can also contribute.

Can low AMH go back up?

A low AMH result can rise modestly when the original value was affected by hormonal contraception, pregnancy, recent ovarian surgery, assay differences, or ordinary biological variation. A change from 0.45 to 0.60 ng/mL may fall within expected variation and does not prove new follicles developed. Age-related follicle loss is not currently reversible with supplements, diet, or exercise. Repeat testing is most useful when done in the same laboratory and linked to a clinical decision.

Should I test AMH on a certain day of my cycle?

AMH can usually be tested on any day of a menstrual cycle because it varies less than FSH, estradiol, and progesterone. Some individuals still have approximately 15% to 30% cycle-related variation, so use the same laboratory and similar testing circumstances when comparing borderline values. Pregnancy and the postpartum period can lower measured AMH and are not ideal for long-term reserve assessment. FSH and estradiol, by contrast, are commonly interpreted on cycle days 2 through 4.

Does birth control cause low AMH?

Combined hormonal contraception can lower measured AMH by roughly 20% to 30% in some users, and this effect is often reversible after stopping. A low AMH while using a pill, patch, ring, or some progestin methods does not automatically mean permanent loss of ovarian reserve. Do not stop contraception solely to repeat AMH without discussing pregnancy prevention and symptom control with the prescriber. The medication name, dose, and duration should be included in the laboratory interpretation.

Can ovarian cyst surgery lower AMH?

Ovarian cyst surgery, especially endometrioma cystectomy, can lower AMH because follicles may be removed or affected during treatment. The reduction is often greater after bilateral surgery, repeat surgery, or extensive cyst-wall removal, and some partial recovery may occur over 6 to 12 months. Endometriomas themselves can also be associated with lower AMH before surgery, so the cause is not always separable. A preoperative fertility preservation discussion is reasonable when future pregnancy is important.

Can I get pregnant naturally with AMH below 1?

Yes, natural pregnancy can occur with AMH below 1.0 ng/mL because AMH does not directly measure whether ovulation, sperm function, tubal patency, fertilization, or implantation will occur this month. The American Society for Reproductive Medicine states that ovarian reserve testing predicts response to stimulation more reliably than unassisted conception. Age, cycle regularity, duration of trying, and partner factors are more informative for short-term natural pregnancy chances. A low result may still justify earlier fertility planning, particularly after age 35.

Low AMH Causes: Age, Surgery and Test Timing

Thomas Klein, MD

Sarah Mitchell, MD, PhD

Prof. Dr. Hans Weber, PhD